Company Information

CIN
Status
Date of Incorporation
09 October 2018
State / ROC
Pune / ROC Pune
Last Balance Sheet
31 March 2023
Last Annual Meeting
30 September 2023
Paid Up Capital
100,000
Authorised Capital
500,000

Directors

Sagar Purushottam Nehate
Sagar Purushottam Nehate
Director/Designated Partner
about 2 years ago
Nilima Swapnil Sonawane
Nilima Swapnil Sonawane
Director/Designated Partner
over 2 years ago
Swapnil Panditrao Sonawane
Swapnil Panditrao Sonawane
Director/Designated Partner
almost 5 years ago
Ashwini Abhay Kulkarni
Ashwini Abhay Kulkarni
Individual Promoter
about 7 years ago

Patents

“Process For Preparing Intermediates Useful In The Manufacture Of Relugolix”

The present invention relates to an industrially feasible, robust, and economically viable process for preparation of ethyl 2-[(2,6-difluoro-benzyl)-ethoxycarbonyl-amino]-4-methyl-5-(4-nitro-phenyl)-thiophene-3-carboxylate (1).

“Preparation Of 3 Ethylbicyclo[3.2.0]Hept 3 En 6 One”

The present invention relates to an industrially feasible, robust, and economically viable process for preparation of 3-ethylbicyclo [3.2.0] hept-3-en-6-one (7). The process produces compound (7) having chiral purity >99%.

“Substantially Pure Ethyl 2 (5 Amino 2 Bromo 4 Fluorophenyl) Acetate And Preparation Thereof”

The present invention relates to substantially pure ethyl 2-(5-amino-2-bromo-4- fluorophenyl) acetate of formula (1) having undesired impurity of formula (5) less than 0.2%. The invention further relates to a process for the preparation of substantially 10 pure ethyl 2-(5-amino-2-bromo-4-fluorophenyl) acetate of ...

Registered Trademarks

Bhisaj Pharma Bhisaj Pharmaceuticals

[Class : 5] Chemico Pharmaceutical Preparations Included In Class 5

Bhisaj Pharma Bhisaj Pharmaceuticals

[Class : 44] Medical Services, Veterinary Services, Hygienic And Beauty Care For Human Beings Included In Class 44